Ryosuke Matsumoto @matsumotory has been appointed as Director and CTO of COGNANO Inc. as of May 1, 2022! Not only will we be a bio yet IT company, but we will be a team that can do bio despite being IT! We are in the process of fusion of biotechnology and IT by digitizing biological information.
Latest News
- 27st Aug 2024Exhibiting at BioJapan2024 in Yokohama
- 31st Jul 2024New Patent Announcement by Cognano: A Novel Cancer-specific Antigen for Triple-negative Breast Cancer and Its Corresponding VHH Antibody Clone
- 31st Jul 2024Presentation of Research Findings at the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer
- 31st Jul 2024Our Participation in Two Upcoming Conferences: San Antonio Breast Cancer Symposium and The 15th World ADC
- 1st Jul 2024Selected for ASTEM's FY24 Kyoto-based Innovative Medical Technology Research and Development Grant Program